摘要
This study reports the design and synthesis of 2-(phenylsulfonyl)quinoline N-hydroxyacrylamides (8a–k). Structure-activity relationship studies focusing on regio-effect of N-hydroxyacrylamide moiety and influence of the sulfonyl linker revealed that N-hydroxy-3-[3-(quinoline-2-sulfonyl)-phenyl]-acrylamide (8f) showed remarkable enzymatic and cellular activity. The GI50values of 8f for HL-60, HCT116, PC-3, and A549 cells were found to be 0.29, 0.08, 0.15, and 0.27 μM, respectively. The compounds are therefore more potent than FDA approved PXD-101 and SAHA. They also have an effect on the acetylation degree of histone H3 and α-tubulin. In in vivo studies, 8f showed marked inhibition of the growth of HCT116 xenografts.
原文 | 英語 |
---|---|
頁(從 - 到) | 92-101 |
頁數 | 10 |
期刊 | European Journal of Medicinal Chemistry |
卷 | 122 |
DOIs | |
出版狀態 | 已發佈 - 2016 |
ASJC Scopus subject areas
- 藥物發現
- 藥理
- 有機化學